Sonoma Pharmaceuticals (SNOA) Free Cash Flow (QoQ) (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 1.92 Mn | -477,555.95 | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.43% |
| Dec 31, 2025 | -25.74% |
| Sep 30, 2025 | 69.59% |
| Jun 30, 2025 | -1,393.66% |
| Mar 31, 2025 | -125.22% |
| Dec 31, 2024 | 71.65% |
| Sep 30, 2024 | 135.77% |
| Jun 30, 2024 | -639.41% |
| Mar 31, 2024 | 115.38% |
| Dec 31, 2023 | 10.38% |
| Sep 30, 2023 | -431.47% |
| Jun 30, 2023 | 91.18% |
| Mar 31, 2023 | -594.20% |
| Dec 31, 2022 | 79.57% |
| Sep 30, 2022 | -19.22% |
| Jun 30, 2022 | -6.79% |
| Mar 31, 2022 | -345.57% |
| Dec 31, 2021 | 75.40% |
| Sep 30, 2021 | -4.48% |
| Jun 30, 2021 | 14.11% |